Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Novo Nordisk A/S Common Stock (NY:NVO)

50.29 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Dec 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 325,245
Open 50.29
Bid (Size) 50.50 (400)
Ask (Size) 50.52 (800)
Prev. Close 50.29
Today's Range 50.29 - 50.29
52wk Range 43.08 - 112.52
Shares Outstanding N/A
Dividend Yield 4.37%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Why Novo Nordisk Stock Topped the Market on Thursday ↗
A proposed new federal law could provide some competitive guardrails for the company's most important product. 
Via The Motley Fool
News headline image
Navigating Nuance: Tech Innovation, Healthcare Revival, and Energy's Evolving Landscape Shape Late 2025 Markets
As December 2025 unfolds, global financial markets are characterized by a delicate balance of cautious optimism and persistent uncertainty. A "Santa Claus rally" sentiment prevails, fueled by... 
Via MarketMinute
Topics Artificial Intelligence Economy Electric Vehicles

Performance

YTD
-42.5%
-42.5%
1 Month
+2.3%
+2.3%
3 Month
-7.4%
-7.4%
6 Month
-38.0%
-38.0%
1 Year
-55.0%
-55.0%

More News

Read More
News headline image
Novo Nordisk (NVO) Q3 2025 Earnings Transcript ↗
Via The Motley Fool
The 2025 Weight-Loss Drug Gold Rush: How Eli Lilly Pulled Ahead, Novo Hit A Snag — And A Swarm Of Biotech Underdogs Are Closing In ↗
Via Stocktwits
Why Did Structure Therapeutics Stock Surge Pre-Market Today? ↗
Via Stocktwits
News headline image
Eli Lilly's Retatrutide Soars: Unprecedented Trial Results Propel Pharma Giant, Ignite Obesity Market
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain
News headline image
Golden Cross Alert: 3 Stocks With Major Upside Potential ↗
Via MarketBeat
News headline image
Warning: This Skyrocketing Stock Has a Hidden Risk ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
3 Absurdly Cheap Stocks That Look Like Steals Right Now ↗
Via The Motley Fool
Topics Economy World Trade
News headline image
Why Wave Life Sciences Stock Crushed it Again Today ↗
Via The Motley Fool
News headline image
Prediction: This Surprising Growth Stock Will Reach -- and Stay in -- the Trillion-Dollar Club in 2026. ↗
Via The Motley Fool
News headline image
5 High Short-Interest Stocks to Buy Before Q1 2026 ↗
Via MarketBeat
News headline image
Why Wave Life Sciences Stock Vaulted 146% Higher on Monday ↗
Via The Motley Fool
News headline image
Why Novo Nordisk Stock Was Melting on Monday ↗
Via The Motley Fool
News headline image
Novo Nordisk (NYSE:NVO) Embodies Quality Investing Principles ↗
Via Chartmill
News headline image
Do These 3 Healthcare Stocks Need a Checkup? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
This Pharmaceutical Giant Fell by 10% After a Setback: Time to Sell the Stock? ↗
Via The Motley Fool
News headline image
Trump Administration Eases Investment Deadlines For Large Pharma Companies: Report ↗
Via Stocktwits
Topics Artificial Intelligence Government Workforce
News headline image
1 Reason to Buy Eli Lilly Hand Over Fist Before the New Year ↗
Via The Motley Fool
News headline image
Medicare Just Cut the Price of Wegovy: Should You Sell Novo Nordisk Stock? ↗
Via The Motley Fool
Topics Economy Government
News headline image
Novo Nordisk Defends Semaglutide Alzheimer’s Trials After Studies Miss Goals ↗
Via Stocktwits
News headline image
The Shifting Tides: How Retail and Institutional Forces Reshape Market Dynamics
Via MarketMinute
Topics Artificial Intelligence Economy Fraud
News headline image
Beyond the Hype: AI’s Quiet Revolution in Niche Sectors Reshapes Industries from Medicine to Agriculture
Via TokenRing AI
Topics Artificial Intelligence Economy Emissions
News headline image
Omeros Corp Sells Immune-System Drug To Novo Nordisk In $2.1B Deal — Retail Shifts Focus To Narsoplimab FDA Call ↗
Via Stocktwits
Topics Intellectual Property
News headline image
Eli Lilly Cuts Prices For Weight Loss Drug Zepbound To $299 A Month As It Takes On Novo Nordisk’s Wegovy ↗
Via Stocktwits
Topics Economy Government

Frequently Asked Questions

Is Novo Nordisk A/S Common Stock publicly traded?
Yes, Novo Nordisk A/S Common Stock is publicly traded.
What exchange does Novo Nordisk A/S Common Stock trade on?
Novo Nordisk A/S Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Novo Nordisk A/S Common Stock?
The ticker symbol for Novo Nordisk A/S Common Stock is NVO on the New York Stock Exchange
What is the current price of Novo Nordisk A/S Common Stock?
The current price of Novo Nordisk A/S Common Stock is 50.29
When was Novo Nordisk A/S Common Stock last traded?
The last trade of Novo Nordisk A/S Common Stock was at 12/11/25 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.